FLT3 and acute myeloid leukemia: The Italian SEIFEM (Sorveglianza Epidemiologica InFezioni nelle EMopatie) group evaluated the incidence of IFD during induction, re‐induction and consolidation therapy with midostaurin + chemotherapy for AML with FLT3 mutations.